Physician profile
David C Tobin
NPI 1649253519
$337.71
in general payments reported to CMS, 2019-2025
10 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $201 · 2020: $40.11 · 2021: $81.74 · 2022: $15.21.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Wright Medical Technology, INC. | $145.02 | 2019 | |
| Melinta Therapeutics, LLC | $41.57 | 2019 | |
| Grt US Holding, INC. | $28.66 | 2020-2021 | |
| Allergan, INC. | $26.55 | 2020 | |
| Organogenesis INC. | $23.66 | 2021 | |
| Davol INC. | $15.73 | 2021 | |
| Kerecis Limited | $15.21 | 2022 | |
| Paratek Pharmaceuticals, INC. | $14.61 | 2021 | |
| Smith+Nephew, INC. | $14.06 | 2019 | |
| Paragon 28, INC. | $12.64 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Tobin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.